Jun. 2 at 2:15 AM
$CGEM trading ~
$16.21, consolidating near 52-week highs following FDA acceptance of the zipalertinib NDA and anticipation for upcoming CLN-978 data at EULAR 2026.
📈 Setup: Strong base building with a massive
$393M cash cushion providing runway into 2029; institutional analysts hold a
$30 consensus target.
🐂 Bull Trigger: A clean daily close above
$16.97 triggers the breakout for a move toward
$20.00 and a test of
$25.00.
🐻 Bear Level: A breakdown below
$14.45 shifts control for a flush to the
$11.00 pivot, opening the door to
$8.35.
📊 Trend: BULLISH — Multiple clinical catalysts and strong liquidity give buyers high conviction.
#cgem #biotech #hovdid
